{"id":"https://openalex.org/W4361950235","doi":"https://doi.org/10.1158/1078-0432.c.6520626.v1","title":"Data from Large-scale Analysis of PDGFRA Mutations in Melanomas and Evaluation of Their Sensitivity to Tyrosine Kinase Inhibitors Imatinib and Crenolanib","display_name":"Data from Large-scale Analysis of PDGFRA Mutations in Melanomas and Evaluation of Their Sensitivity to Tyrosine Kinase Inhibitors Imatinib and Crenolanib","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361950235","doi":"https://doi.org/10.1158/1078-0432.c.6520626.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6520626.v1","doi":"https://doi.org/10.1158/1078-0432.c.6520626.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6520626.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6520626.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113785275","display_name":"Jie Dai","orcid":"https://orcid.org/0000-0003-3478-2170","observed_orcids":["https://orcid.org/0000-0003-3478-2170","https://orcid.org/0009-0006-6497-0841"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jie Dai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101777042","display_name":"Yan Kong","orcid":"https://orcid.org/0000-0002-6368-2112","observed_orcids":["https://orcid.org/0000-0002-6368-2112","https://orcid.org/0000-0002-2266-7872"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Kong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018372804","display_name":"Lu Si","orcid":"https://orcid.org/0000-0002-2123-9761","observed_orcids":["https://orcid.org/0000-0002-2123-9761"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lu Si","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104109855","display_name":"Zhihong Chi","orcid":"https://orcid.org/0000-0001-6257-6775","observed_orcids":["https://orcid.org/0000-0001-6257-6775","https://orcid.org/0009-0005-1504-7842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhihong Chi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112345035","display_name":"Chuanliang Cui","orcid":"https://orcid.org/0000-0001-6455-0843","observed_orcids":["https://orcid.org/0000-0001-6455-0843"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chuanliang Cui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035685296","display_name":"Xinan Sheng","orcid":"https://orcid.org/0000-0001-9359-0975","observed_orcids":["https://orcid.org/0000-0001-9359-0975"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xinan Sheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112249057","display_name":"Lili Mao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lili Mao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100670857","display_name":"Siming Li","orcid":"https://orcid.org/0000-0001-7077-0404","observed_orcids":["https://orcid.org/0000-0001-7077-0404"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Siming Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Bin Lian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bin Lian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100979292","display_name":"Ruifeng Yang","orcid":"https://orcid.org/0009-0007-4177-7923","observed_orcids":["https://orcid.org/0009-0007-4177-7923"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruifeng Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070763250","display_name":"Shujing Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shujing Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110634","display_name":"Xiaowei Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaowei Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100419613","display_name":"Jun Jie Guo","orcid":"https://orcid.org/0000-0001-9867-2689","observed_orcids":["https://orcid.org/0000-0001-9867-2689"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Guo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pdgfra-mutation","display_name":"PDGFRA mutation","score":0.9959999918937683},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9129999876022339},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":1.0},{"id":"https://openalex.org/keywords/crenolanib","display_name":"crenolanib","score":1.0},{"id":"https://openalex.org/keywords/acral-melanoma","display_name":"acral melanoma","score":0.7419999837875366},{"id":"https://openalex.org/keywords/mucosal-melanoma","display_name":"mucosal melanoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/kit-mutations","display_name":"KIT mutations","score":0.8379999995231628},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.8059999942779541},{"id":"https://openalex.org/keywords/nras-mutation","display_name":"NRAS mutation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.9300000071525574},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5669999718666077},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.859000027179718}],"concepts":[{"id":"https://openalex.org/C37307934","wikidata":"https://www.wikidata.org/wiki/Q18030422","display_name":"PDGFRA","level":4,"score":0.962067723274231},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5674566030502319},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.5261544585227966},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.503950297832489},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.4877088963985443},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.46593350172042847},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3669162392616272},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3598548173904419},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35193943977355957},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33292073011398315},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.21883660554885864},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15724295377731323},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1522344946861267},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11653828620910645},{"id":"https://openalex.org/C2775922572","wikidata":"https://www.wikidata.org/wiki/Q83567","display_name":"GiST","level":3,"score":0.10555335879325867},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09219273924827576},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.0},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6520626.v1","doi":"https://doi.org/10.1158/1078-0432.c.6520626.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6520626.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6520626.v1","doi":"https://doi.org/10.1158/1078-0432.c.6520626.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6520626.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2101452250","https://openalex.org/W2054379745","https://openalex.org/W2022165580","https://openalex.org/W7071891722","https://openalex.org/W2582417631","https://openalex.org/W2156153763","https://openalex.org/W2590712091","https://openalex.org/W1986949331","https://openalex.org/W2079641245","https://openalex.org/W1507105187"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Platelet-derived":[2],"growth":[3],"factor":[4],"receptor":[5],"\u03b1":[6],"(PDGFRA)":[7],"is":[8],"a":[9,220],"target":[10],"for":[11,74],"tyrosine":[12],"kinase":[13,194],"inhibitor":[14],"(TKI)-based":[15],"targeted":[16],"therapy.":[17],"Dysregulation":[18],"of":[19,42,54,83,86,99,113,115,149,160,177,183,196,223],"PDGFRA":[20,28,43,101,128,150,235],"has":[21],"been":[22,34],"reported":[23,167],"in":[24,30,44,77,88,110,123,180,191,219],"many":[25],"cancers.":[26],"However,":[27],"mutations":[29,41,76,87,107,119,129,148,164,207,216,236],"melanomas":[31],"have":[32],"not":[33,166],"well":[35],"studied.":[36],"We":[37],"analyzed":[38,95],"the":[39,51,154,193,205],"genetic":[40,75,147],"Chinese":[45],"patients":[46,230],"with":[47,135,141,231],"melanoma":[48,69,224,232],"and":[49,59,81,92,102,117,125,143,157,169,175,213,241],"determined":[50],"inhibitory":[52],"potency":[53,188],"TKIs,":[55],"such":[56],"as":[57],"imatinib":[58,91,190,212,240],"crenolanib,":[60],"on":[61],"mutant":[62],"PDGFRA.":[63,84,184,197],"Experimental":[64],"Design:":[65],"Of":[66],"note,":[67],"351":[68],"tissue":[70],"samples":[71],"were":[72,94,108,120,151,165,208],"examined":[73],"exons":[78],"12,":[79],"14,":[80],"18":[82],"Activities":[85],"response":[89],"to":[90,131,153,210],"crenolanib":[93,242],"by":[96],"Western":[97],"blotting":[98],"tyrosine-phosphorylated":[100],"cell":[103],"proliferation":[104],"assays.":[105],"Results:PDGFRA":[106],"observed":[109],"4.6%":[111],"(16":[112],"351)":[114],"melanomas,":[116],"these":[118],"mainly":[121],"detected":[122,218],"acral":[124],"mucosal":[126],"melanomas.":[127,162],"seem":[130],"be":[132],"mutually":[133],"exclusive":[134],"KIT":[136],"mutations,":[137],"but":[138],"may":[139,237],"coexist":[140],"BRAF":[142],"NRAS":[144],"mutations.":[145],"The":[146],"unrelated":[152],"age,":[155],"thickness,":[156],"ulceration":[158],"status":[159],"primary":[161],"Thirteen":[163],"before,":[168],"five":[170],"(P577S,":[171],"V658A,":[172],"R841K,":[173],"H845Y,":[174],"G853D)":[176],"them":[178],"resulted":[179],"strong":[181],"autophosphorylation":[182],"Crenolanib":[185],"showed":[186],"higher":[187],"than":[189],"inhibiting":[192],"activity":[195],"Except":[198],"that":[199,229],"V658A":[200],"mutation":[201],"was":[202],"imatinib-resistant,":[203],"all":[204],"other":[206],"sensitive":[209],"both":[211],"crenolanib.":[214],"Conclusions:PDGFRA":[215],"are":[217],"small":[221],"population":[222],"patients.":[225],"Our":[226],"study":[227],"suggests":[228],"harboring":[233],"certain":[234],"benefit":[238],"from":[239],"treatment.":[243],"Clin":[244],"Cancer":[245],"Res;":[246],"19(24);":[247],"6935\u201342.":[248],"\u00a92013":[249],"AACR.":[250]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-05T00:00:00"}